Latest News

Latest News2022-06-07T16:37:06+00:00

713 Novel protease activatable linker with tumor targeting motifs enhances the retention of cytokine prodrug and active cytokine at disease site and demonstrates improved efficacy in preclinical model

By |June 9th, 2022|Categories: Biotech, News, Technology, Trending|

Abstract Background An emerging class of new protease-activatable prodrugs designed to enhance on-target activity and reduce off-target toxicity are being actively developed. Cytokines are complex immune mediators which display potent [...]

Abstract 1745: On demand cytokine, a novel cytokine prodrug, demonstrates robust single agent efficacy without systemic toxicity in syngeneic tumor models

By |April 9th, 2021|Categories: Biotech, Technology, Trending|

Abstract Recombinant IL-2 (aldesleukin) is a potent T cell proliferation and differentiation factor and is an approved immunotherapy for advanced melanoma and renal cell carcinoma. Despite the remarkable and durable [...]

Boehringer taps Trutino to bag safer, more efficacious cytokines

By |February 26th, 2020|Categories: Biotech, Technology, Trending|

Boehringer Ingelheim has struck a deal with Trutino Biosciences to develop three cytokine therapies. The deal tasks Trutino with applying a platform designed to yield safer, more effective cytokines to [...]

Biocom’s 10th Annual Global Life Science Partnering Conference, February 25-27 2020, La Jolla, CA

By |February 25th, 2020|Categories: Biotech, News, Technology|

This event is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Industry leaders [...]

Go to Top